Publications
Differential Response of Engineered Human Cardiac Tissues to Delta and Omicron COVID-19 Virus." Journal of the American Heart Association 12, no. 12 (2023).
"Effect of type I interferon on engineered pediatric skeletal muscle: A promising model for juvenile dermatomyositis." Rheumatology (Oxford, England) (2023).
"Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome." Scientific Reports 13, no. 1 (2023).
"PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system." Apl Bioengineering 7, no. 4 (2023).
"The Potential of Deep Learning to Advance Clinical Applications of Computational Biomechanics." Bioengineering 10, no. 9 (2023): 1066.
"Chemotherapeutic drug screening in 3D-Bioengineered human myobundles provides insight into taxane-induced myotoxicities." Iscience 25, no. 10 (2022).
"Differential microRNA profiles of intramuscular and secreted extracellular vesicles in human tissue-engineered muscle." Frontiers in Physiology 13 (2022).
"In Situ Fabrication and Perfusion of Tissue-Engineered Blood Vessel Microphysiological System." Methods in Molecular Biology (Clifton, N.J.) 2375 (2022): 77-90.
"Late onset cardiovascular dysfunction in adult mice resulting from galactic cosmic ray exposure." Iscience 25, no. 4 (2022).
"Patient- and Ventilator-Specific Modeling to Drive the Use and Development of 3D Printed Devices for Rapid Ventilator Splitting During the COVID-19 Pandemic." In Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 137-149. Vol. 13352 LNCS. 2022.
"Principles for the design of multicellular engineered living systems." Apl Bioengineering 6, no. 1 (2022).
"Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells." J Tissue Eng Regen Med 16, no. 2 (2022): 128-139.
"Biofabrication of tissue engineering vascular systems." Apl Bioengineering 5, no. 2 (2021).
"Development and Application of Endothelial Cells Derived From Pluripotent Stem Cells in Microphysiological Systems Models." Frontiers in Cardiovascular Medicine 8 (2021).
"Differentiation and characterization of human iPSC-derived vascular endothelial cells under physiological shear stress." Star Protocols 2, no. 2 (2021).
"Emulating Early Atherosclerosis in a Vascular Microphysiological System Using Branched Tissue-Engineered Blood Vessels." Advanced Biology 5, no. 4 (2021).
"The NIH Somatic Cell Genome Editing program." Nature 592, no. 7853 (2021): 195-204.
"Application of Oxidative Stress to a Tissue-Engineered Vascular Aging Model Induces Endothelial Cell Senescence and Activation." Cells 9, no. 5 (2020).
"Biomechanical effects on microRNA expression in skeletal muscle differentiation." Aims Bioengineering 7, no. 3 (2020): 147-164.
"The future of biomedical engineering: Bioengineering of organoids and tissue development." Current Opinion in Biomedical Engineering 13 (2020): A1-A2.
"Gene Expression Differences In Three-dimensional Myobundles Compared To Two-dimensional Myocultures." Medicine and Science in Sports and Exercise 52, no. 7S (2020): 781-782.
"Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle." Tissue Engineering and Regenerative Medicine 17, no. 6 (2020): 801-813.
"Human iPSCs Stretch to Improve Tissue-Engineered Vascular Grafts." Cell Stem Cell 26, no. 2 (2020): 136-137.
"iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome." Stem Cell Reports 14, no. 2 (2020): 325-337.
"Modeling early stage atherosclerosis in a primary human vascular microphysiological system." Nature Communications 11, no. 1 (2020).
"